Home » Newsletters » BioWorld

BioWorld

March 17, 1995

View Archived Issues

S-LAMININ-MINUS MICE ADD IN VIVO DATA TO MAPPING NEUROMUSCULAR

GLAXO CLEARS FINAL HURDLE IN WELLCOME ACQUISITION

APPOINTMENTS AND ADVANCEMENTS

VIVUS PROPOSES PUBLIC OFFERING OF 2.1M SHARES

GENTA DOWNSIZES TO FOCUS ON GEOMATRIX, CANCER DRUGS

INSTITUTE OF MEDICINE SAYS FIAU TRAGEDY WAS NOT PREVENTABLE

WARNER-LAMBERT, BASF UNITE IN ICE-INHIBITING EFFORT

IDEC SIGNS POTENTIAL $57M DEAL WITH GENENTECH

FDA REFORM CLINTON UNVEILS HIGHLIGHTS TO REINVENT DRUG, DEVICE

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 17, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.